window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 2, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

CDMOs & Manufacturing

  • CDMOs & Manufacturing,Drug Development,Manufacturing,RNA Therapeutics

    Codexis signs siRNA manufacturing deal for cardiovascular programme

    Codexis has signed an agreement to manufacture siRNA for a [...]

    March 23, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Infectious Diseases,Partnerships & Funding,Vaccines

    Evotec unit secures BARDA deal to optimise Ebola antibody manufacturing

    Just – Evotec Biologics has been selected by BARDA to [...]

    March 23, 2026
  • Biotech,CDMOs & Manufacturing,Clinical Trials,Funding,Healthcare leadership,Oncology

    Mestag Therapeutics raises $40M and adds leadership ahead of cancer trial

    Mestag Therapeutics has raised $40 million and appointed two senior [...]

    March 23, 2026
  • CDMOs & Manufacturing,Cell & Gene Therapy,Manufacturing,Technology and platforms

    Sartorius launches Eveo platform targeting cell therapy manufacturing bottlenecks

    Sartorius has launched a new platform designed to address manufacturing [...]

    March 17, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Events and Conferences,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    Fujifilm Biotechnologies unveils ShunzymeX purification technology for biologics

    FUJIFILM Biotechnologies has unveiled ShunzymeX, a purification technology designed to [...]

    March 6, 2026
  • Antibody drug conjugates,Biologics & Biosimilars,Biomanufacturing,CDMOs & Manufacturing,Drug Development,Research & Development,Technology and platforms

    Lonza expands bioconjugate capabilities at Oss site to support ADC development

    Lonza expands its Advanced Synthesis capabilities at Oss, integrating ADC [...]

    February 19, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Drug Delivery & Formulation,European biotech,Facilities and infrastructure,Healthcare leadership,Manufacturing,Movers & Shakers,Pharmaceuticals and therapeutics

    Axplora expands lyophilisation capacity at Le Mans

    Axplora is investing several million euros to expand lyophilisation capacity [...]

    February 19, 2026
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Facilities and infrastructure,Ingredients,Manufacturing,Technology and platforms

    DFE Pharma launches continuous manufacturing platform with Gericke to support formulation development

    DFE Pharma has launched a new continuous manufacturing platform in [...]

    February 18, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Facilities and infrastructure,Manufacturing,Pharmaceuticals and therapeutics,Supply Chain & Logistics,Sustainability

    Fujifilm invests £400M in UK biomanufacturing expansion with new Teesside single-use facility

    FUJIFILM Biotechnologies has opened a £400M biomanufacturing and process development [...]

    February 13, 2026
  • CDMOs & Manufacturing,Clinical Trials,Data Management,Technology and platforms

    PSI launches AI platform to improve clinical trial site selection and enrolment

    PSI CRO has launched SYNETIC, an AI-powered semantic knowledge platform [...]

    February 2, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top